发明名称 ORF2 PROTEIN OF PCV2 SUBTYPE A (PCV2A) FOR USE IN CROSS-PROTECTION
摘要 Vaccination methods to control PCV2 infection with different PCV2 subtypes are disclosed. Specifically, a PCV2 subtype a (PCV2a) ORF2 proteins or immunogenic compositions comprising a PCV2a ORF2 protein are used in a method for the treatment or prevention of an infection with PCV2 of a different subtype, the reduction, prevention or treatment of clinical signs caused by an infection with PCV2 of a different subtype, or the prevention or treatment of a disease caused by an infection with PCV2 of a different subtype.
申请公布号 US2014322267(A1) 申请公布日期 2014.10.30
申请号 US201414263193 申请日期 2014.04.28
申请人 HAIWICK Gregory;HERNANDEZ Luis;JOHNSON Wesley Scott;MUEHLENTHALER Christine Margaret;VAUGHN Eric Martin 发明人 HAIWICK Gregory;HERNANDEZ Luis;JOHNSON Wesley Scott;MUEHLENTHALER Christine Margaret;VAUGHN Eric Martin
分类号 A61K39/12;A61K39/108;A61K39/08;A61K39/02;A61K39/215;A61K39/145;A61K39/04;A61K39/085;A61K39/09;A61K39/23;A61K39/245;A61K39/05;A61K39/235 主分类号 A61K39/12
代理机构 代理人
主权项 1. A method for the treatment or prevention of an infection with PCV2 of a subtype other than subtype a, the reduction, prevention or treatment of clinical signs caused by an infection with PCV2 of a subtype other than subtype a, or the prevention or treatment of a disease caused by an infection with PCV2 of a subtype other than subtype a comprising the use of a PCV2 subtype a (PCV2a) ORF2 protein or immunogenic composition comprising PCV2a ORF2 protein.
地址 Ankeny IA US